// App-Quantinova.ai

BSH19‐PO‐143 : Prevalence of small PNH clones and their prognostic significance in patients tested for unusual indications: a single center experience

Researchers

Presenter

  • B. Fattizzo

Principal Investigators

  • A. Dunlop

  • R. Ireland

  • S. Kassam

  • D. Yallop

  • G. Mufti

  • J. Marsh

  • A. Kulasekararaj

Medical Centers

  • Gastroenterology Department, Kings College Hospital, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Autoimmune (AI)

  • Blood/haematological Diseases

  • Oncology (ONC)

Disease

  • Paroxysmal nocturnal hemoglobinuria

  • Chronic myelomonocytic leukemia

  • Myeloid neoplasms

  • Myelodysplastic Syndrome

  • Chronic Myelogenous Leukemia

  • Immune thrombocytopenia

  • Acute myelocytic leukemia

  • Thrombocytopenia

  • Aplastic anemia

  • Myelofibrosis

  • Neutropenia

  • Venous thrombosis

  • Anemia

Biomarkers

  • Glycosylphosphatidylinositol

  • Lactate dehydrogenase

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved